Cargando…

Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer

Tumor necrosis factor (TNF) family members participate in the body’s antitumor immunity response and influence tumor prognosis and treatment response. However, little is known about the roles of TNF family members in small cell lung cancer (SCLC). Therefore, we conducted the first comprehensive inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhihui, Wu, Peng, Zhang, Chaoqi, Luo, Yuejun, Zhang, Guochao, Zeng, Qingpeng, Wang, Lide, Yang, Zhaoyang, Sun, Nan, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637339/ https://www.ncbi.nlm.nih.gov/pubmed/34867972 http://dx.doi.org/10.3389/fimmu.2021.745769

Ejemplares similares

Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma
por: Zhang, Zhihui, et al.
Publicado: (2021)

m(6)A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

m(6)A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer
por: Wu, Peng, et al.
Publicado: (2022)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Comprehensive analyses of N (6)‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer
por: Luo, Yuejun, et al.
Publicado: (2022)

The landscape of m(6)A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance
por: Zhang, Chaoqi, et al.
Publicado: (2021)

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

RNA N (6)‐methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential
por: Zhang, Zhihui, et al.
Publicado: (2021)

Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes
por: Zhang, Chaoqi, et al.
Publicado: (2020)

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Adjuvants for Coronavirus Vaccines
por: Liang, Zhihui, et al.
Publicado: (2020)

Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas
por: Zhao, Wei-jiang, et al.
Publicado: (2021)

Regulation of the PKCθ-NF-κB Axis in T Lymphocytes by the Tumor Necrosis Factor Receptor Family Member OX40
por: So, Takanori, et al.
Publicado: (2012)

Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo
por: Josien, Régis, et al.
Publicado: (2000)

Novel Insights on the Regulation of B Cell Functionality by Members of the Tumor Necrosis Factor Superfamily in Jawed Fish
por: Tafalla, Carolina, et al.
Publicado: (2018)

Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma
por: Bo, Xiaobo, et al.
Publicado: (2017)

Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer
por: Chen, Dexin, et al.
Publicado: (2021)

A promising self-nanoemulsifying adjuvant with plant-derived saponin D boosts immune response and exerts an anti-tumor effect
por: Luo, Xing, et al.
Publicado: (2023)

New Insights in the Immunobiology of IL-1 Family Members
por: van de Veerdonk, Frank L., et al.
Publicado: (2013)

Granulocytes: New Members of the Antigen-Presenting Cell Family
por: Lin, Ang, et al.
Publicado: (2017)

Editorial: IL-1 Family Members in Health and Disease
por: Brint, Elizabeth, et al.
Publicado: (2019)

Editorial: Ying and Yang Members of the Tumor Necrosis Factor Superfamily: Friends or Foes in Immune-Mediated Diseases and Cancer
por: Giwa, Adebola, et al.
Publicado: (2017)

It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
por: Yao, Shiya, et al.
Publicado: (2023)

B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients
por: Xie, Huyang, et al.
Publicado: (2018)

An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Case report: Brain metastasis necrosis with immune checkpoint inhibitors plus chemotherapy for advanced non-small cell lung cancer
por: Niu, Lishui, et al.
Publicado: (2022)

The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study
por: Gormley, J A, et al.
Publicado: (2011)

Promoter Binding and Nuclear Retention Features of Zebrafish IRF Family Members in IFN Response
por: An, Li-Li, et al.
Publicado: (2022)

The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy
por: Wang, Zeyu, et al.
Publicado: (2021)

High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma
por: Chen, Yanfang, et al.
Publicado: (2022)

Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation
por: Zhao, Tingting, et al.
Publicado: (2023)

Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2
por: Xu, Shengshan, et al.
Publicado: (2023)

Murine Insulin Growth Factor-like (IGFL) and Human IGFL1 Proteins Are Induced in Inflammatory Skin Conditions and Bind to a Novel Tumor Necrosis Factor Receptor Family Member, IGFLR1
por: Lobito, Adrian A., et al.
Publicado: (2011)

Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors
por: Sobash, Philip T., et al.
Publicado: (2022)

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer
por: Zhou, Mingxuan, et al.
Publicado: (2022)

IL-1 Family Members in Cancer; Two Sides to Every Story
por: Baker, Kevin J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f33tf1v23jielbhsm46dlv5bo4